-
Comparison between liraglutide and dulaglutide on the incidence or progression of eye and kidney complications
-
Associations of finerenone with reduced insulin resistance in patients with type 2 diabetes and chronic kidney disease: A real‐world observational study
-
Aggressive Natural Killer Cell Leukemia: A Rare and Rapidly Progressive Hematologic Malignancy—Case Report and Literature Review
-
Research Progress on Transitional Care for Hemophilia Patients from Pediatric to Adult Services: Focusing on Disease Severity and Care Continuity
-
Prevalence of diagnostic Mendelian kidney disease variants in type 2 diabetes with and without diabetic kidney disease
-
Association of hematologic-inflammatory indices and all-cause mortality in adults with type 2 diabetes and hypertension
-
Association Between Time-Averaged Serum Uric Acid and Renal Outcomes in Patients with Type 2 Diabetes Mellitus with Chronic Kidney Disease: A Multicenter Retrospective Cohort Study
-
Combined sleep behaviors, mediating biomarkers, and incident vascular complications among individuals with type 2 diabetes: A prospective study in UK Biobank
-
The Incidence of Hemolytic and Serologic Transfusion Reactions Among Patients with Hematological Malignancies at Mbarara Regional Referral Hospital and the Uganda Cancer Institute, in Uganda
-
Bispecific Antibodies in Hematologic Malignancies in the Outpatient and Community Settings
-
Prevalence, Risk Factors, and Prognostic Impact of Spontaneous Tumor Lysis Syndrome in Aggressive Hematologic Malignancies: Experience From the Clinical Hematology Department, University of Dakar
-
A Clinical Investigation of Hypoxic Red Blood Cell Administration in Patients with Transfusion-Dependent Hematological Malignancies and Burns
-
Do the treatment selection factors emphasized in clinical guidelines—Chronic kidney disease, cardiovascular disease, and heart failure—contribute to the risk of urinary tract infections during the administration of sodium‐glucose cotransporter‐2 inhibitors?
-
ATG Plus Post-Transplantation Cyclophosphamide Improves EBV-DNA Clearance and GVHD in Patients of Adult Chronic Active Epstein-Barr Virus Disease Undergoing Allogeneic HSCT
-
Identification of Patient Clusters with Distinct Disease Progression Patterns Utilizing a Nationwide Finnish Population with Type 2 Diabetes
-
The complexity of associations between patient satisfaction, glycemic control and complications in diabetes care
-
Intensified multifactorial intervention leads to long‐term benefit on kidney outcomes in advanced diabetic kidney disease: A 10‐year follow‐up of the DNETT‐Japan trial
-
Malignancy-Associated Hemophagocytic Lymphohistiocytosis: An Experience of 15 Years in Polish Pediatric Hematology Centers
-
IGF2BP3 inhibition: another home run for RNA-binding protein targeting in hematological malignancies
-
Impact of Cardiometabolic Risk Markers on the Incidence and Progression Arterial Stiffness in Patients With Prediabetes
-
Trends and disparities in valvular heart disease–related mortality among adults with diabetes mellitus in the United States: 1999–2024
-
Low Subjective Cardiovascular Disease Risk Perceptions among Hypertensive Patients in Addis Ababa, Ethiopia
-
Assessment of plasma glycated CD59 in type 2 diabetic patients with diabetic retinopathy and nephropathy: a study of combined microvascular complications
-
Predictors of Tuberculosis and Non-Communicable Disease Comorbidities Among Newly Enrolled Tuberculosis Patients, Southern Ethiopia
